214 related articles for article (PubMed ID: 33506637)
1. Grain-sized moxibustion promotes NK cell antitumour immunity by inhibiting adrenergic signalling in non-small cell lung cancer.
Hu D; Shen W; Gong C; Fang C; Yao C; Zhu X; Wang L; Zhao C; Zhu S
J Cell Mol Med; 2021 Mar; 25(6):2900-2908. PubMed ID: 33506637
[TBL] [Abstract][Full Text] [Related]
2. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer.
Yan X; Yao C; Fang C; Han M; Gong C; Hu D; Shen W; Wang L; Li S; Zhu S
Int J Biol Sci; 2022; 18(2):585-598. PubMed ID: 35002511
[No Abstract] [Full Text] [Related]
3. Tanshinone IIA enhances susceptibility of non-small cell lung cancer cells to NK cell-mediated lysis by up-regulating ULBP1 and DR5.
Sun Y; Gong C; Ni Z; Hu D; Ng W; Zhu X; Wang L; Si G; Yan X; Zhao C; Yao C; Zhu S
J Leukoc Biol; 2021 Aug; 110(2):315-325. PubMed ID: 33909909
[TBL] [Abstract][Full Text] [Related]
4. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
5.
Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G
Front Immunol; 2019; 10():454. PubMed ID: 30967859
[TBL] [Abstract][Full Text] [Related]
6. Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer.
Al Omar SY; Marshall E; Middleton D; Christmas SE
Immunology; 2011 May; 133(1):94-104. PubMed ID: 21342183
[TBL] [Abstract][Full Text] [Related]
7. CD11b(-)CD27(-) NK cells are associated with the progression of lung carcinoma.
Jin J; Fu B; Mei X; Yue T; Sun R; Tian Z; Wei H
PLoS One; 2013; 8(4):e61024. PubMed ID: 23565296
[TBL] [Abstract][Full Text] [Related]
8. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.
Esendagli G; Bruderek K; Goldmann T; Busche A; Branscheid D; Vollmer E; Brandau S
Lung Cancer; 2008 Jan; 59(1):32-40. PubMed ID: 17825949
[TBL] [Abstract][Full Text] [Related]
9. Rocaglamide enhances NK cell-mediated killing of non-small cell lung cancer cells by inhibiting autophagy.
Yao C; Ni Z; Gong C; Zhu X; Wang L; Xu Z; Zhou C; Li S; Zhou W; Zou C; Zhu S
Autophagy; 2018; 14(10):1831-1844. PubMed ID: 29969944
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non-Small Cell Lung Cancer.
Lu T; Ma R; Mansour AG; Bustillos C; Li Z; Li Z; Ma S; Teng KY; Chen H; Zhang J; Villalona-Calero MA; Caligiuri MA; Yu J
Cancer Immunol Res; 2024 Jun; 12(6):731-743. PubMed ID: 38572955
[TBL] [Abstract][Full Text] [Related]
11. PTTG1 knockdown enhances radiation-induced antitumour immunity in lung adenocarcinoma.
Chen Z; Cao K; Hou Y; Lu F; Li L; Wang L; Xia Y; Zhang L; Chen H; Li R; Chang L; Li W
Life Sci; 2021 Jul; 277():119594. PubMed ID: 33984357
[TBL] [Abstract][Full Text] [Related]
12. The anti-lung cancer activity of SEP is mediated by the activation and cytotoxicity of NK cells via TLR2/4 in vivo.
Ke M; Wang H; Zhang M; Tian Y; Wang Y; Li B; Yu J; Dou J; Xi T; Zhou C
Biochem Pharmacol; 2014 May; 89(1):119-30. PubMed ID: 24630931
[TBL] [Abstract][Full Text] [Related]
13. Autolymphocyte therapy--I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes.
Gold JE; Osband ME
Eur J Cancer; 1994; 30A(12):1871-82. PubMed ID: 7880620
[TBL] [Abstract][Full Text] [Related]
14. EPHA5 mutation impairs natural killer cell-mediated cytotoxicity against non-small lung cancer cells and promotes cancer cell migration and invasion.
Zhang J; Zhang Z; Song W; Liu J
Mol Cell Probes; 2020 Aug; 52():101566. PubMed ID: 32234341
[TBL] [Abstract][Full Text] [Related]
15. Transcutaneous Electrical Acupoint Stimulation Improves Immunological Function During the Perioperative Period in Patients With Non-Small Cell Lung Cancer Undergoing Video-Assisted Thoracic Surgical Lobectomy.
Tu Q; Yang Z; Gan J; Zhang J; Que B; Song Q; Wang Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806477. PubMed ID: 30381011
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of NK cell-mediated lysis of non-small lung cancer cells by nPKC activator, ingenol 3,20 dibenzoate.
Gong C; Yao C; Xu Z; Ni Z; Zhu X; Wang L; Yan X; Zhou W; Zhu S
Mol Immunol; 2017 Mar; 83():23-32. PubMed ID: 28092804
[TBL] [Abstract][Full Text] [Related]
17. The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer.
Bruno A; Focaccetti C; Pagani A; Imperatori AS; Spagnoletti M; Rotolo N; Cantelmo AR; Franzi F; Capella C; Ferlazzo G; Mortara L; Albini A; Noonan DM
Neoplasia; 2013 Feb; 15(2):133-42. PubMed ID: 23441128
[TBL] [Abstract][Full Text] [Related]
18. Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases.
Dhupkar P; Gordon N; Stewart J; Kleinerman ES
Cancer Med; 2018 Jun; 7(6):2654-2664. PubMed ID: 29733528
[TBL] [Abstract][Full Text] [Related]
19. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
Iversen TZ
Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis.
Ihara S; Kida H; Arase H; Tripathi LP; Chen YA; Kimura T; Yoshida M; Kashiwa Y; Hirata H; Fukamizu R; Inoue R; Hasegawa K; Goya S; Takahashi R; Minami T; Tsujino K; Suzuki M; Kohmo S; Inoue K; Nagatomo I; Takeda Y; Kijima T; Mizuguchi K; Tachibana I; Kumanogoh A
Cancer Res; 2012 Jun; 72(12):2990-9. PubMed ID: 22659452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
